JPMorgan Downgrades ResMed (RMD) to Neutral
Tweet
Share
E-mailGet Alerts RMD Hot Sheet
Price: $220.37 -1.82%
Rating Summary:
11 Buy, 12 Hold, 2 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Rating Summary:
11 Buy, 12 Hold, 2 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Join SI Premium – FREE
JPMorgan downgraded ResMed (NYSE: RMD) from Overweight to Neutral.
For more ratings news on ResMed click here and for the rating history of ResMed click here.
Shares of ResMed closed at $33.61 yesterday.
For more ratings news on ResMed click here and for the rating history of ResMed click here.
Shares of ResMed closed at $33.61 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Resmed Announces Appointment of Carol Burt as Lead Director and Planned Retirement of Director Ron Taylor
- ResMed names Carol Burt as lead director as Ron Taylor retires
- JPMorgan Downgrades EyePoint Inc. (EYPT) to Neutral
Create E-mail Alert Related Categories
DowngradesRelated Entities
JPMorganSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
